Skip to content

Victoria Banks tells her Lenire story to NPR’s Morning Edition

Victoria banks uses Lenire

David Petrelli/Victoria Banks

Nashville based singer-songwriter Victoria Banks joined NPR’s Morning Edition to talk about how Lenire helped her tinnitus so she could get back to “listening to music, writing music, and performing music.”

“My brain is now focusing on other things”, she said.

Banks tried taking dietary supplements and exercise before she read about Lenire, which was approved by the FDA in March 2023. She then sought out Dr. Brian Fligor, a Lenire certified clinician, and after treatment with Lenire the buzz of tinnitus is no longer distracting.

Lenire Patient, Bruce Freeman

Bruce Freeman, another Lenire patient and a scientist at the University of Pittsburgh Medical Center, spoke to the show and said, “he’s impressed with the results of the research”, that points to significant improvements among clinical trial participants with tinnitus and that it has “helped him manage the condition”.

Freeman experienced a return of his symptoms when he stopped using the device. “Without it the tinnitus got worse,” he says. Then, when he resumed use, it improved.

Lenire Partner Clinician, Dr. Brian Fligor

Dr. Fligor mentioned that Lenire is “quickly becoming is go to” for treating tinnitus while discussing the clinical trial results of the device which resulted in it becoming the first and only device of its kind approved by the US FDA for the treatment of tinnitus.

Another patient of Dr. Fligor’s, Elliot Gerberg, previously joined NPR to discuss his journey with Lenire. Read Elliot’s story here.

Read the full interview at https://www.npr.org/sections/health-shots/2024/04/15/1244501055/tinnitus-hearing-loss-ringing-ear-noise

Subscribe to our Newsletter

Our dedicated newsletter for healthcare professionals will keep you up to date with the Lenire® treatment and research.

In order to subscribe you to our newsletter, we require your consent to send marketing communications to you. Please tick the box below to consent to:

You can unsubscribe from these communications at any time. For more information view our privacy policy.

By clicking subscribe, you consent to allow Neuromod to store and process the personal information submitted above to provide you with the content requested.